These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 10624139)
1. [The factors that determine participation in cervical cancer screening in the state of Morelos]. Lazcano-Ponce EC; Moss S; Cruz-Valdez A; Alonso de Ruiz P; Casares-Queralt S; Martínez-León CJ; Hernández-Avila M Salud Publica Mex; 1999; 41(4):278-85. PubMed ID: 10624139 [TBL] [Abstract][Full Text] [Related]
2. The positive experience of screening quality among users of a cervical cancer detection center. Lazcano-Ponce EC; Moss S; Cruz-Valdez A; de Ruíz PA; Martínez-León CJ; Casares-Queralt S; Hernández-Avila M Arch Med Res; 2002; 33(2):186-92. PubMed ID: 11886720 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey. Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084 [TBL] [Abstract][Full Text] [Related]
4. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland]. Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397 [TBL] [Abstract][Full Text] [Related]
5. [Cervical cancer screening: knowledge of Pap smear benefits and utilization in Mexico]. Aguilar-Perez JA; Leyva-López AG; Angulo-Nájera D; Salinas A; Lazcano-Ponce EC Rev Saude Publica; 2003 Feb; 37(1):100-6. PubMed ID: 12488926 [TBL] [Abstract][Full Text] [Related]
6. The cervical cancer screening program in Mexico: problems with access and coverage. Lazcano-Ponce EC; Nájera-Aguilar P; Buiatti E; Alonso-de-Ruiz P; Kuri P; Cantoral L; Hernández-Avila M Cancer Causes Control; 1997 Sep; 8(5):698-704. PubMed ID: 9328191 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study. Hernández-Avila M; Lazcano-Ponce EC; de Ruíz PA; Romieu I Int J Epidemiol; 1998 Jun; 27(3):370-6. PubMed ID: 9698122 [TBL] [Abstract][Full Text] [Related]
8. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard. Açikgöz A; Ergör G Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227 [TBL] [Abstract][Full Text] [Related]
9. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. Nygård JF; Skare GB; Thoresen SØ J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929 [TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer in an African setting. Cronjé HS; Beyer E Int J Gynaecol Obstet; 2007 Aug; 98(2):168-71. PubMed ID: 17585915 [TBL] [Abstract][Full Text] [Related]
11. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Lazcano-Ponce EC; Buiatti E; Nájera-Aguilar P; Alonso-de-Ruiz P; Hernández-Avila M Cancer Causes Control; 1998 May; 9(3):241-51. PubMed ID: 9684704 [TBL] [Abstract][Full Text] [Related]
12. Use of and attitudes and knowledge about pap smears among women in Kuwait. El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218 [TBL] [Abstract][Full Text] [Related]
13. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System. MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754 [TBL] [Abstract][Full Text] [Related]
14. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro. Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356 [TBL] [Abstract][Full Text] [Related]
15. Cervical Cancer Screening and Sexual Risky Behaviors among a Population of Hispanic Origin. González D; Suárez EL; Ortiz AP Womens Health Issues; 2015; 25(3):254-61. PubMed ID: 25840931 [TBL] [Abstract][Full Text] [Related]
16. [The coverage of cervical screening in Hungary]. Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975 [TBL] [Abstract][Full Text] [Related]
17. Determinants of Cervical Cancer Screening Uptake in Kurdish Women Living in Western Iran, 2014. Aminisani N; Fattahpour R; Abedi L; Shamshirgaran SM Asian Pac J Cancer Prev; 2016; 17(8):3763-7. PubMed ID: 27644614 [TBL] [Abstract][Full Text] [Related]
18. [Awareness of cervical cancer prevention among patients of gynecological outpatient clinic]. Ulman-Włodarz I; Nowosielski K; Romanik M; Pozowski J; Jurek M Ginekol Pol; 2011 Jan; 82(1):22-5. PubMed ID: 21473052 [TBL] [Abstract][Full Text] [Related]
19. [Pap test coverage and adequacy in the South and Northeast of Brazil]. Correa Mda S; Silveira DS; Siqueira FV; Facchini LA; Piccini RX; Thumé E; Tomasi E Cad Saude Publica; 2012 Dec; 28(12):2257-66. PubMed ID: 23288059 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region. Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]